Condition: Atrial Flutter Typical · Sponsor: Imricor Medical Systems
The VISABL-AFL clinical investigation is a prospective, single-arm, multi-center, interventional, Investigational Device Exemption (IDE) trial. The primary objectives of VISABL-AFL are to assess the safety and efficacy of radiofrequency (RF) ablation of type-I atrial flutter performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.
This description comes directly from the study's public registry record.
Kate Lindborg · 952-818-8400 · kate.lindborg@imricor.com
Jennifer Somerville · 952-594-4138 · jennifer.somerville@imricor.com
Always discuss trial participation with your own doctor first.
| Johns Hopkins University (JHU) | Baltimore, Maryland, United States | Recruiting |
| University of Virginia (UVA) | Charlottesville, Virginia, United States | Not Yet Recruiting |
| Virginia Commonwealth University | Richmond, Virginia, United States | Not Yet Recruiting |
| l'institut Cardiologique Paris Sud (ICPS) | Massy, France | Recruiting |
| Amsterdam University Medical Center (AUMC) | Amsterdam, Netherlands | Recruiting |
| University Hospital of Vaud (CHUV) | Lausanne, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05904548